Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Res Pharm Sci ; 9(4): 295-9, 2014.
Article in English | MEDLINE | ID: mdl-25657801

ABSTRACT

The role of opioid receptor and voltage dependent calcium channels on the kindling induced by the convulsant pentylenetetrazole (PTZ) were investigated in the rats. Experiment involved 24 rats which were divided into four groups. Kindling was established with PTZ in subconvulsive dose (37.5 mg/kg i.p.) every 48 h and effects were observed within 20 min using five-point scoring system. All animals were kindled to three consecutive-stage five seizures and their stability was tested. Saline, verapamil (calcium channel blocker), naloxone (opioid antagonist) or both of them were then administrated 20 min before PTZ application. Convulsant parameters were significantly (P<0.05) reduced by verapamil. Naloxone had no significant effect on the seizure expression of fully kindled animals, whereas simultaneous application of naloxone and verapamil had profound inhibitory effect on all seizure parameters. The results of the present study suggest that naloxane increased the inhibitory effect of verapamil on the seizure induced by PTZ kindling.

2.
Neuroscience ; 134(2): 415-23, 2005.
Article in English | MEDLINE | ID: mdl-15961249

ABSTRACT

The relationship between epilepsy, modeled here by pentylenetetrazol kindling, and learning deficits, modeled here by long-term potentiation (LTP), was studied. The field excitatory postsynaptic potentials and population spikes (PS) were recorded from strata radiatum and pyramidale, respectively, in urethane-anesthetized rat dorsal hippocampus CA1 area upon stimulation of Schaffer collaterals. To induce LTP, a 100 Hz primed-burst stimulation protocol was used. Experiments were carried out at approximately 30 days after the last pentylenetetrazol dose. The effects of voltage dependent calcium channel blocker verapamil and N-methyl-D-aspartate receptor antagonist MK-801 on LTP expression were examined. Tetanic stimulation elicited both field excitatory postsynaptic potential LTP and PS LTP in control animals, and LTP-induction of the PS in control animals was attenuated by MK-801, but not by verapamil. By contrast, kindled rats showed LTP of the PS only. MK-801 reduced the extent of potentiation of PS amplitude and verapamil inhibited the PS amplitude potentiation, completely. The results suggest that seizure induction modifies mechanisms underlying LTP induction and causes a shift in the form of LTP expression. The pentylenetetrazol-kindling-induced increase in PS LTP is sensitive to verapamil and not to MK-801 and therefore primarily dependent on activation of voltage dependent calcium channels rather N-methyl-D-aspartate receptors. Kindling may lead to a shift in synaptic plasticity thresholds much like the shift that occurs during aging, and such alterations may contribute to deficits in learning and memory.


Subject(s)
Epilepsy/physiopathology , Hippocampus/physiopathology , Long-Term Potentiation/physiology , Animals , Anticonvulsants/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Calcium Channels/physiology , Convulsants , Dizocilpine Maleate/pharmacology , Electric Stimulation , Epilepsy/chemically induced , Excitatory Amino Acid Antagonists/pharmacology , Hippocampus/drug effects , Kindling, Neurologic , Male , Pentylenetetrazole , Rats , Rats, Inbred Strains , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/physiology
3.
Neuroscience ; 126(4): 955-66, 2004.
Article in English | MEDLINE | ID: mdl-15207329

ABSTRACT

To elucidate chronic actions of brain-derived neurotrophic factor (BDNF) on GABAergic synapses, we examined effects of a long-term application of BDNF for 10-15 days on autapses (synapses) of solitary GABAergic neurons cultured from rat visual cortex. Solitary neuron preparations were used to exclude a possible contamination of BDNF actions on excitatory neurons in dissociated neuron culture or slice preparations. Neurons were confirmed to be GABAergic pharmacologically with bicuculline, a selective antagonist for GABAA receptors and immunocytochemically with antibody against glutamic acid decarboxylase 65, a GABA synthesizing enzyme. To evaluate GABAergic synaptic function, evoked and/or miniature inhibitory postsynaptic currents (IPSCs) were recorded in the whole-cell voltage-clamp mode. The treatment with BDNF at a concentration of 100 ng/ml enhanced the amplitude of evoked IPSCs and the frequency of miniature IPSCs. In contrast, BDNF did not have a detectable effect on the amplitude of miniature IPSCs and the paired pulse ratio of IPSCs evoked by two, successive activations. To evaluate morphological changes, neurons were immunocytochemically stained with antibodies against microtubule-associated protein 2, to visualize somatodendritic region and synapsin I, to visualize presynaptic sites. The quantitative analysis indicated that BDNF increased the area of soma, the numbers of primary dendrites and dendritic branching points, the total length of dendrites and the number of synaptic sites. Such an action of BDNF was seen in both subgroups of GABAergic neurons, parvalbumin-positive and -negative neurons. To visualize functionally active presynaptic sites, neurons were stained with a styryl dye, FM1-43. BDNF increased the number of stained sites that was correlated with the frequency of miniature IPSCs. These results suggest that the chronic treatment with BDNF promotes dendritic and synaptic development of GABAergic neurons in visual cortex.


Subject(s)
Brain-Derived Neurotrophic Factor/pharmacology , Neural Inhibition/drug effects , Neurons/drug effects , Synapses/drug effects , Visual Cortex/cytology , Analysis of Variance , Animals , Animals, Newborn , Antibodies/pharmacology , Bicuculline/pharmacology , Carbazoles/pharmacology , Cell Count/methods , Cell Size , Cells, Cultured , Drug Interactions , Electric Stimulation/methods , Enzyme Inhibitors/pharmacology , GABA Antagonists/pharmacology , Glutamate Decarboxylase/metabolism , Immunohistochemistry/methods , Indole Alkaloids , Male , Membrane Potentials/drug effects , Microtubule-Associated Proteins/metabolism , Neural Inhibition/physiology , Neurons/cytology , Parvalbumins/metabolism , Patch-Clamp Techniques , Peptide Fragments/metabolism , Pyridinium Compounds/metabolism , Quaternary Ammonium Compounds/metabolism , Rats , Rats, Sprague-Dawley , Receptor, trkB/immunology , Synapses/physiology , Synapsins/metabolism
4.
Epilepsy Res ; 47(1-2): 141-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11673028

ABSTRACT

In this study the role of adenosine A(1) receptors of CA1 region of the hippocampus on amygdala-kindled seizures was investigated in rats. Results obtained showed that in kindled animals, bilateral injection of N(6)-cyclohexyladenosine (CHA), an adenosine A(1) receptor agonist, at doses of 0.1, 1 and 10 microM into the CA1 region of the hippocampus significantly decreased the afterdischarge duration and stage 5 seizure duration and increased the latency to stage 4 seizure, but there were no changes in seizure stage. Also, bilateral injection of 1,3-dimethyl-8-cyclopenthylxanthine (CPT), an adenosine A(1) receptor antagonist, at doses of 0.5 and 1 microM into the CA1 region of the hippocampus could not produce any changes in the seizure parameters. Intrahippocampal pretreatment of CPT (1 microM) before CHA (0.1 and 1 microM), reduced the effects of CHA on seizure parameters significantly. Thus, it may be suggested that CA1 region of the hippocampus plays an important role in spreading seizure spikes from the amygdala to other brain regions and activation of adenosine A(1) receptors in this region, participates in anticonvulsant effects of adenosine agonists.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/administration & dosage , Amygdala/drug effects , Anticonvulsants/administration & dosage , Hippocampus/drug effects , Kindling, Neurologic/drug effects , Animals , Dose-Response Relationship, Drug , Male , Purinergic P1 Receptor Agonists , Purinergic P1 Receptor Antagonists , Rats , Rats, Sprague-Dawley , Seizures/drug therapy , Seizures/physiopathology , Xanthines/pharmacology
5.
Brain Res ; 898(1): 82-90, 2001 Apr 13.
Article in English | MEDLINE | ID: mdl-11292451

ABSTRACT

The effects of pentylenetetrazol-kindling on synaptic transmission and the effectiveness of θ pattern primed-bursts (PBs) for the induction of long-term potentiation (LTP) of population excitatory postsynaptic potentials and population spikes were investigated in hippocampal CA1 of pentylenetetrazol-kindled rats. Experiments were carried out in the control and kindled animals at two post-kindling periods, i.e., 48-144 h (early phase) and 30-33 days (long lasting phase). Field potentials (population excitatory postsynaptic potentials, pEPSPs; and population spikes, PSs) were recorded at the stratum radiatum and the stratum pyramidale following stimulation of the stratum fibers, respectively. PBs were delivered to stratum fibers and PB potentiation was assessed. The results showed that 48-144 h after kindling there was no significant difference for pEPSP slope and PS amplitude between two groups. But at 30-33 days after kindling, the pEPSP slope in the stratum radiatum of kindled animals decreased, whereas the amplitude of PSs increased compared to those of controls. Shortly after kindling, control animals had normal LTP of pEPSP slope and PS amplitude in response to PBs, but kindled rats lack LTP of pEPSP slope and PBs induced LTP of PS amplitude in most of kindled animals. In 30-33 days after kindling, PB potentiation was not observed in the stratum radiatum of kindled animals but PBs induced LTP of PS amplitude, which was significantly greater than that of control animals. The effect is compatible with the hypothesis, which postulates kindling-associated functional deficit in hippocampus, especially CA1, as an explanation for the behavioral deficits seen with the kindling model of epilepsy.


Subject(s)
Convulsants/pharmacology , Hippocampus/physiology , Kindling, Neurologic , Long-Term Potentiation/physiology , Pentylenetetrazole/pharmacology , Action Potentials/physiology , Animals , Electric Stimulation , Excitatory Postsynaptic Potentials/physiology , Male , Rats , Rats, Inbred Strains , Time Factors
6.
Epilepsy Res ; 37(1): 37-43, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10515173

ABSTRACT

Possible anticonvulsant effects of 2-chloroadenosine injected focally into the perirhinal cortex of amygdala kindled rats were investigated over a 2 h period. Animals were microinfused (1 microl) with 2-chloroadenosine (2-CLA; 5, 10, 15, 25 and 100 nM) or artificial cerebrospinal fluid applied through a cannula located in the perirhinal cortex. At the doses employed, 2-CLA significantly reduced afterdischarge duration and stage 5 seizure duration. The latency to stage 4 seizure was increased only at the highest dose of 2-CLA (100 nM), while even at this dose no significant change in seizure stage could be seen. The maximum effect of 2-CLA was obtained 30 min after microinfusion of the drug. Pre-treatment (intraperirhinal cortex) of animals with the nonselective adenosine antagonist, caffeine (50 microM; 1 microl), blocked the anticonvulsant activity of 2-CLA. These results suggest that adenosine receptors located in the perirhinal cortex may play an important role in the suppression of seizure activity elicited from the amygdala.


Subject(s)
2-Chloroadenosine/pharmacology , Amygdala/physiology , Anticonvulsants/pharmacology , Kindling, Neurologic , Olfactory Pathways/physiology , 2-Chloroadenosine/antagonists & inhibitors , Adenosine/antagonists & inhibitors , Analysis of Variance , Animals , Anticonvulsants/antagonists & inhibitors , Caffeine/pharmacology , Dose-Response Relationship, Drug , Injections , Male , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Seizures/physiopathology , Seizures/prevention & control
7.
Brain Res ; 775(1-2): 37-42, 1997 Nov 14.
Article in English | MEDLINE | ID: mdl-9439826

ABSTRACT

The seizure-modulating effects of 2-chloroadenosine (2-CLA) infused directly into the amygdala were investigated. Different groups of amygdala-kindled rats were infused (1 microliter) with 2-CLA (0.25, 1, 10 and 25 nM), caffeine (200 microM and 2 mM), a combination of the two or artificial cerebrospinal fluid (ACSF) applied directly through a cannula located in the amygdala. Infusion of 2-CLA dramatically suppressed seizure stage (SS), after discharge duration (ADD) and stage 5 seizure duration (S5D), while the latency to bilateral forelimb clonus (S4L) was significantly prolonged. These anticonvulsant effects were evident after 5 min, reached a maximum at the 60 min time point and were still detectable 360 min post-2-CLA infusion. Pretreatment with caffeine blocked the anticonvulsant effects of 2-CLA dose-dependently. These results may suggest that in amygdaloid-kindled rats, adenosine receptors located in the amygdala play a major role in the expression of the anticonvulsant activity of 2-CLA.


Subject(s)
2-Chloroadenosine/pharmacology , Amygdala/physiology , Anticonvulsants/pharmacology , Kindling, Neurologic/drug effects , Seizures/prevention & control , 2-Chloroadenosine/administration & dosage , Animals , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Injections , Male , Purinergic P1 Receptor Antagonists , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...